*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

read results a bit more thoroughly...better than i thought...have they finally got their act together? keeping an eye on them..always said if they could show profit they would interest me again.......

Treble,
You have indeed said that in the past and you have also called it right a few times too! That's enough credit for you-lol

I posted this over on 'Dark Side' this morning so think I should post me work here too :-)

Morning all,
We have seen a further 10 distributors added since last year bringing the total to 70 and this in my opinion is quite amazing!
Amazing in that when I look back to when I first invested well dabbled in MDW after doing a bit of research compared to where they are now!Think it was the TWST article that got me at the time or was that after?-lol

What I'm trying to lead on to is that PSAwatch has been a bit of a millstone around MDW's neck over the years which has led to great debate (nothing wrong in that)but in my opinion scared investors away over the last few years,as they have seen this as MDW!

No offence pinkfish but copied your post below as a recent example of what we have seen over the years:


"pinkfish - 5 Feb'08 - 13:26 - 14807 of 14822


Don't take it that MDW are the only company working on an accurate rapid PSA test for point of care.

They can lose any lead very quickly, to a larger group.

There is no time to waste."

The above post and again I'm sure you posted it in the best intentions is both right and wrong in my opinion!
There are indeed POC PSA tests already in the market place and yes there are POC PSA tests of a high accuracy starting on the approval trail.
MDW have not got a lead as PSAwatch is not out there or just starting to be in EU but I know what you mean but this is the language yet again that filters through,that MDW are only a PSA test company which they are certainly not!!!!

"There is no time to waste"-This brings me to my main point (ED-there will be others,just wait and see!):

MDW are a company that is basically Split into two divisions that being Urology with sub-divisions of Ultrasound diagnostics and Urodynamics,the second is Biochemistry which is where PSAwatch,Bioscan and Bladder Cancer Diagnosis(BTA)comes under.

This then leads on to the second half year results(2007)leading to a profit for the first time in MDW's history with much greater profits easily seen through 2008 which will be shown in the summer Interims and all this is without the Biochemistry division apart from BTA being involved to some degree!

I think I have made this following speech 20 times over the years-lol:
MDW are a major player on the global stage within their sector ie Urology but what we are seeing now/soon(at last)is the Biochemistry division taking a hold and as we have all said before,has the potential to be a massive revenue generator just as the disposables are in the Urology division for example.

This is why I believe there is no rush or should I clarify that by saying there obviously hasn't been so why rush or get panicked now after all these years? or a ! or even both-lol.

This is key as in the Bioscan is being developed to carry out various tests and not just the PSA test!The Prostate is part of Urology and obviously a major part if your a man but Urology covers both men and WOMEN so if MDW which they have and are doing very well at,build up their business on the grounds of Urology then PSAwatch will be a very attractive bonus for anyone in the market for buying new equipment (all or most of MDW's equipment can 'talk' to each other and send any information to a central database to be stored on patients records for example) .I am sure MDW sales staff have been promoting PSAwatch/Bioscan in the USA/everywhere and with CE approvals already given then the FDA approvals although long-winded will be judged in the buying circles as a foregone conclusion-imo.

After the recent 'approach' I am (for what my opinion is worth-lol)now agreeing that six monthly sales figures or the odd major deal announcement is not enough at this stage in MDW's history.I don't want to dwell (ED-I told you there would be more!) on why the 'approach' failed it's history now but I don't want to see anymore while we are at these low SP levels for a company that has been seen to have completed what it set out to do a few years ago and with profits now being realised!

I think MDW do indeed and pretty quickly need to get shareholders interest by doing something dynamic!On the otherhand I can't fault MDW so far so maybe I'll just shut-up and let them get on with it!(Ed-thank God for that!)





ooooops forgot,this is just me humbly opinion dyor ect ect ect

Quick Edit-to priorities in order of importance for where we are now,in my opinion only:

1 Products on sale now

2 Disposables for above products and more

3 Bioscan (on sale now/soon in EU)

4 PSAwatch (on sale now/soon in EU)

5 Other tests for the Bioscan

Mediwatch attended Arab Health in Dubai 28 January to 1 February 2008. Arab Health is the major health show for the Middle East and other regions.

On the back of the strong regional economy, the show was well attended . The quality of attendees was better than recent shows with plenty of focused buyers attending. Mediwatch saw strong interest in the Bioscan, Multiscan and the portable G2/G3.

Substantial orders were taken on the stand. Eleven existing dealers received formal training on the new products and a further three dealers signed up. All in all, an excellent show!

Looks like Bard Uk will be competing for sales with Elemental Healthcare relating to the Bardscan II in UK and Ireland (Bardscan is MDW's Portascan badged for Bard):

Bardscan II Ultrasound scanner


A VISIBLE DIFFERENCE IN BLADDER SCANNING

Bardscan II; Portable, accurate Ultrasound bladder scanning

Completely non-invasive, portable ultrasound bladder volume device. Measures urine volume with Real-time scanning technology.
Bardscan II offers not only high accuracy and precision, but with real-time technology the potential to identify co-existing pathologies, eg enlarged prostate and bladder calculi.

Bardscan II supplied with One year manufacturer's warranty.

With Bardscan II you needn't wait to see the picture.

http://www.bardireland.ie/main/main.asp


http://www.barduk.com/main/product.asp?sectionTypeId=2&sectionId=5&productId=55


http://www.barduk.com/inc/getFile.asp?fileId=78&filetype=file

Well,that was a dramatic morning!

VA Requests $94 Billion for Veterans in FY 09 Budget

February 4, 2008
(Printable Version)



Peake: VA Will Provide Timely, Accessible and High-Quality Care

WASHINGTON Honoring the nations commitment to care for the newest generation of combat veterans and service members from other conflicts and eras, Secretary of Veterans Affairs Dr. James B. Peake announced today President Bush is seeking a budget of $93.7 billion in fiscal year 2009 for the Department of Veterans Affairs (VA), with health care and disability compensation receiving most of the funding.

If Congress accepts the White Houses budget request, VAs budget would be $3.4 billion more than the current spending level and nearly double the budget in effect when President Bush took office seven years ago.

http://www1.va.gov/opa/pressrel/pressrelease.cfm?id=1449



and

Family members too............

Our Nation's Veterans

Of the 25 million veterans currently alive, nearly three of every four served during a war or an official period of hostility. About a quarter of the nation's population -- approximately 70 million people -- are potentially eligible for VA benefits and services because they are veterans, family members or survivors of veterans.

http://www.va.gov/about_va/

Two TR1's announced today,it's all go! :-)

TR1-Ashcourt Holdings

TR1-Barclays Stockbrokers Ltd

mick that is all great but share pice has lost 45% of its value in 2 weeks........i know you dont like to mention anything negative but surely it is worth a small mention......told you you should have taken your cash at 14p....you could have nearly twice as many shares

Evening Treble,
As you know I have two long term holdings which are just that! I don't mind negative comments if they can be backed up but one liners like yours are just silly-lol.

Look at the chart and you will see the SP can swing 40% in one day!

I could have taken the cash,yes but I may not have been able to buy back in if the SP had continued upwards,as said before I don't trade MDW or GON just add to when funds allow.I do trade with other companies but not these two as these are me long term winners :-)

All coming together rather nicely methinks :-)

Which strangely enough are both hitting profit status at around the same time!

"In considering the improved trading performance in the second half of the year,it is particularly pleasing to report that the Mediwatch Group had a profit before tax of 93,000 in the second half compared to the reported loss before tax of 913,000 in the first half of the year ended 31 October 2007."

Nicked from the dark side and thank's to 'pinkfish'


Advanced Prostate Cancer Can Be Predicted By PSA Testing
Main Category: Prostate / Prostate Cancer
Article Date: 15 Feb 2008 - 3:00 PST

email to a friend printer friendly view / write opinions rate article newsletters


Visitor Ratings:
Healthcare Professional:
General Public:

>> rate this article

A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan-Kettering Cancer Center in New York and Lund University in Sweden. The findings, published in the online open- access journal BMC Medicine, should help physicians be able to identify men who would benefit from intensive prostate cancer screenings over their lifetime.

Previously, the team's research has shown that a single PSA test at age 50 or younger could predict the presence of prostate cancer in men up to 25 years in advance of diagnosis. "This latest study is a unique, natural experiment to test whether we can predict advanced prostate cancer many years before it is diagnosed," said lead author Hans Lilja, MD, PhD, a clinical chemist with joint appointments in the Departments of Surgery and Medicine at MSKCC.

Prostate cancer is the most common cancer in American men after lung cancer. This year, more than 230,000 new cases will be diagnosed, and according to the American Cancer Society, more than 27,000 men died from prostate cancer in 2006.

The findings are based on the research team's analysis of blood samples collected between 1974 and 1986 as part of a large, population-based study of middle aged men called the MalmPreventative Medicine study. The study cohort, in Malm Sweden, included 161 men who had been diagnosed with advanced prostate cancer by 1999 and men of a similar age who had not developed cancer by that time.

The results showed that the total PSA level was an accurate predictor of advanced cancer diagnosis in men later in life. The majority, 66 percent, of advanced cancers were seen in men whose PSA levels were in the top 20 percent (total PSA > 0.9 ng/ml). The average length of time from blood test to cancer diagnosis was 17 years.

While this data does not have any immediate implications for general prostate cancer screening guidelines, Dr. Lilja adds, "We have found that a single PSA test taken at or before age 50 is a very strong predictor of advanced prostate cancer diagnosed up to 25 years later. This suggests the possibility of using an early PSA test determine which men should be the focus of the most intensive screening efforts."

Vigilant, targeted screenings in high- risk men could allow physicians to intervene when the cancer is at an early stage.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The research was funded by grants from the National Cancer Institute, the Swedish Cancer Society, and the European Union Sixth Framework Program. Dr. Hans Lilja holds patents for free PSA and hK2 assays.

Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose, and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide. For more information, go to http://www.mskcc.org/.

Source: Jeanne D'Agostino
Memorial Sloan-Kettering Cancer Center


http://www.medicalnewstoday.com/articles/97454.php

One-stop clinics 'are the future'

http://news.bbc.co.uk/1/hi/health/7248132.stm

Super-surgeries: for and against

Synmed are now advertising PSAwatch along with the whole of the MDW range,which is nice! :-)



http://www.synectics.se/psawatch.asp


SynMed Medicinteknik AB is the continuation of Synectics Medical AB and Medtronic Synectics AB. We are based in Stockholm, Sweden, and have extensive know-how of the diagnostic products we have been marketing and selling during the last 20 years.



When Medtronic decided to discontinue the service of old Synectics products, we have been approached by many distributors and direct customers outside Sweden about service issues on their equipment. Naturally we want to extend this service to you and not only for our customers in Sweden.

Nicked from the dark side:

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study

This is quite an interesting article from Jan/Feb 2008 relating to Ultrasound for the detection of blader volume.The Bardscan mentioned is of course MDW's Portascan re-badged for Bard and the 'real time with operator intervention' system is MDW's Multiscan.The BVI-2500 or even the 3000 is toy town stuff,in my opinion.

The future

As relative costs fall, and portability increases bladder scanners that
patients can carry about themselves will become more widely available.
It will be an important tool for patients to assess their own
bladder volume before self catheterisation.
Advances also have allowed these scanners to estimate bladder
weight to give an indication whether the bladder wall may be thickened
secondary to bladder outflow obstruction. In the future they
may give an estimation of whether there are any lesions in the bladder
e.g. clots, tumour as well as commenting on whether the bladder
is filled with urine or not.

At time of writing there are essentially three philosophies of
portable bladder scanning: small non-imaging devices like the
Bladdersan 6100, real time systems with automated edge detection
(e.g. Bardscan) and real time with operator intervention (e.g.
Mediwatch, Sonosite). Any system based around windows computers
and are thus heavier, have boot-up delays, and are subject to
some of the vagaries of a computer; crashing, power use etc. Given
the existing success of such an automated device it is difficult to see
the progression of the field as anything except in that direction. By
obviating the image the device can be made even smaller and thus
more portable.

Conclusion

A cost-conscious urological (and general medical) community has
embraced the bladder scan device because it now offers an accurate
and reliable bladder volume estimation which can be obtained
in a compact, relatively inexpensive unit, without need for a special
technician. Compared with catheterisation it is cost effective and
risk free. Ultrasonography has become an important extension of
the urological examination because it is quick, safe, non-invasive,
relatively inexpensive, widely available, accurate, and reliable.



http://www.pinpointmedical.com/uploads/pdfs/945A.pdf

A little tick-up on low volume,hmmmmmm.

PSA test could predict Prostate Cancer

By MedHeadlines Feb 20th, 2008 Category: Cancer, Medical Research, Prevention, Prostate Cancer

Scientists may have found a better way to predict the eventual onset of prostate cancer. Men who have not yet reached the age of 50 can now be tested with a single PSA test which may help to determine if they will develop the cancer later on. Early treatment could then be initiated and prevention of this form of cancer could be increased.
The reason for this renewed hope in the PSA test s a comes from a promising group of test results whcih was indicated by a group of men whose blood sample were analyzed between the years of 1974 and 1986. Later, in 1999, 161 men from the original group were shown to have avoided the diagnosis of cancer and evidence suggests that the PSA test was a reliable indication of this before the fact. Sixty-six percent of advanced cancers were capable of being identified early on as these men all had a PSA level in the top 20 percent. The average length of time from blood test to a diagnosis of cancer was 17 years which would give ample time to implement preventative measures.
Further studies in this area have, at the very least, become justified by the results of the earlier study and this could result in further confirmation in the future. Eventually, it could be determined that targeted screenings in men who are especially high-risk could help physicians to identify those men who would benefit from preventative measures.
Prostate cancer is the second most common cancer in American men. Over 27,000 men died from it in 2006 and it is estimated that there will be over 230,000 new cases diagnosed in 2008. If the PSA test proves to be effective, this could be a giant leap in a bright new future for many individuals.

http://medheadlines.com/2008/02/20/psa-test-could-predict-prostate-cancer/

Source: Memorial Sloan-Kettering Cancer Center